Finance

Lists
Why is 600380 up 2.63%?
Dive Deeper
600380:SHA
Joincare Pharmaceutical Group Ind. Co.
CNÂĄ10.16
+2.63%
(+0.26) 1D
Sep 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600380...
Open
CNÂĄ9.93
High
CNÂĄ10.23
Low
CNÂĄ9.86
Mkt. cap
18.59B
Avg. vol.
18.14M
Volume
31.63M
P/E ratio
15.53
52-wk high
CNÂĄ12.85
52-wk low
CNÂĄ9.08
EPS
CNÂĄ0.65
Shares outstanding
1.94B
No. of employees
14K
Open
CNÂĄ9.93
High
CNÂĄ10.23
Low
CNÂĄ9.86
Mkt. cap
18.59B
Avg. vol.
18.14M
Volume
31.63M
P/E ratio
15.53
52-wk high
CNÂĄ12.85
52-wk low
CNÂĄ9.08
EPS
CNÂĄ0.65
Shares outstanding
1.94B
No. of employees
14K
News stories
From web sources and news partners
About Joincare Pharmaceutical Group Ind. Co.
CEO-
Employees13.6K
FoundedDec 18, 1992
Headquarters-
SectorPharmaceutical industry
Websitejoincare.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.58B
3.74B
3.72B
2.86B
Cost of goods sold
1.26B
1.51B
1.37B
1.35B
Cost of revenue
1.26B
1.51B
1.37B
1.35B
Research and development expenses
319.86M
342.00M
233.70M
277.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26B
1.32B
1.10B
727.15M
Operating expense
1.53B
1.80B
1.37B
1.03B
Total operating expenses
2.78B
3.31B
2.74B
2.38B
Operating income
797.29M
426.27M
979.97M
477.33M
Other non operating income
-49.47M
45.09M
-35.19M
32.02M
EBT including unusual items
779.99M
513.57M
1.04B
564.16M
EBT excluding unusual items
845.47M
496.11M
1.04B
537.69M
Income tax expense
99.15M
93.11M
153.39M
81.41M
Effective tax rate
12.71%
18.13%
14.79%
14.43%
Other operating expenses
-59.93M
148.93M
39.82M
31.28M
Net income
306.27M
244.33M
414.97M
232.68M
Net profit margin
8.56%
6.54%
11.15%
8.13%
Earnings per share
-
-
-
-
Interest and investment income
143.56M
111.66M
113.93M
112.08M
Interest expense
-21.09M
-20.23M
-15.50M
-17.38M
Net interest expenses
122.47M
91.43M
98.43M
94.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
991.20M
620.96M
1.17B
679.37M
Gain or loss from assets sale
-1.85M
4.07M
-
6.99M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps